Question 1

What are the potential side effects of anlotinib and the chemotherapy regimen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer clinical trial (NCT04111913). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer clinical trial (NCT04111913). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer clinical trial (NCT04111913). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific health conditions that would prevent me from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer clinical trial (NCT04111913). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer clinical trial (NCT04111913). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial impact my overall treatment plan and goals?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer clinical trial (NCT04111913). Contact the study team or your healthcare provider for specific answers.

What this study is about